Literature DB >> 10229236

Global elimination of trachoma: how frequently should we administer mass chemotherapy?

T Lietman1, T Porco, C Dawson, S Blower.   

Abstract

The World Health Organization has recommended repeat mass drug administration as part of their global initiative to eliminate blinding trachoma by the year 2020. The efficacy of repeat treatment will be tested empirically, but the results will not be available for many years, and recommendations for the necessary frequency of treatment are needed immediately. We have developed a mathematical model that uses available epidemiological data from a variety of countries. We recommend, based on our analysis, that in areas where trachoma is moderately prevalent (<35% in children), it should be treated annually, but hyperendemic areas (>50% in children), it should be treated biannually.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229236     DOI: 10.1038/8451

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  59 in total

1.  Can we eliminate trachoma?

Authors:  T Lietman; A Fry
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  What more is there to learn about trachoma?

Authors:  M Melese; W Alemayehu; B Gaynor; E Yi; J P Whitcher; T M Lietman
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

3.  Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.

Authors:  B D Gaynor; K A Holbrook; J P Whitcher; S O Holm; H C Jha; J S P Chaudhary; R C Bhatta; T Lietman
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

4.  Trachoma, antibiotics and randomised controlled trials.

Authors:  B Shapiro; K Dickersin; T Lietman
Journal:  Br J Ophthalmol       Date:  2006-12       Impact factor: 4.638

5.  What's new in azithromyin?

Authors:  Anthony Solomon; Matthew Burton
Journal:  Community Eye Health       Date:  2004-12

6.  Coinfection Dynamics of Two Diseases in a Single Host Population.

Authors:  Daozhou Gao; Travis C Porco; Shigui Ruan
Journal:  J Math Anal Appl       Date:  2016-04-19       Impact factor: 1.583

7.  The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up.

Authors:  Nicholas C Grassly; Michael E Ward; Shirley Ferris; David C Mabey; Robin L Bailey
Journal:  PLoS Negl Trop Dis       Date:  2008-12-02

Review 8.  Strategies to control trachoma.

Authors:  Anu A Mathew; Angus Turner; Hugh R Taylor
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

9.  The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control.

Authors:  Manoj Gambhir; Maria-Gloria Basáñez; Matthew J Burton; Anthony W Solomon; Robin L Bailey; Martin J Holland; Isobel M Blake; Christl A Donnelly; Ibrahim Jabr; David C Mabey; Nicholas C Grassly
Journal:  PLoS Negl Trop Dis       Date:  2009-06-16

10.  Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution.

Authors:  Takele Lakew; Wondu Alemayehu; Muluken Melese; Elizabeth Yi; Jenafir I House; Kevin C Hong; Zhaoxia Zhou; Kathryn J Ray; Travis C Porco; Bruce D Gaynor; Thomas M Lietman; Jeremy D Keenan
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.